Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Predicting FIX Activity in Prophylaxis Patients Using Recombinant FIX Fc Fusion Protein for Treatment of Bleeding Episodes

Jerry S Powell, MD, Margareth Ozelo, MD PhD, Margaret V. Ragni, MD MPH, John Pasi, MBChB, PhD FRCP, FRCPath, David J. Perry, MD PhD FRCP, FRCPath, Ying Zhu, MPH, Baisong Mei, MD PhD, Glenn F Pierce, MD PhD, Lian Li, PhD, Brian Robinson, MD

Blood (2014) 124 (21): 2842.

https://doi.org/10.1182/blood.V124.21.2842.2842

Published: 2014

Journal Articles

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously-Treated Children with Severe Hemophilia a (Kids-ALONG)

Guy Young, MD, Johnny N. Mahlangu, MBBCh, MMed, FCPath, Roshni Kulkarni, MD, Beatrice Nolan, MB, MRCPI, FRCPATH, Raina Liesner, MA MBBChir MDFRCP FRCPath MRCPCH, John Pasi, MBChB, PhD FRCP, FRCPath, Christopher Barnes, MB BS, Srividya Neelakantan, PhD, Giulia Gambino, MSc, Lynda M Cristiano, MD, Christopher Barnowski, MD, Glenn F Pierce, MD PhD, Geoffrey A. Allen, MD

Blood (2014) 124 (21): 1494.

https://doi.org/10.1182/blood.V124.21.1494.1494

Published: 2014

Journal Articles

Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Doris V. Quon, MD PhD, Johnny N. Mahlangu, MBBCh, MMed, FCPath, Amy D Shapiro, John Pasi, MBChB, PhD FRCP, FRCPath, Ying Zhu, MPH, Glenn F Pierce, MD PhD, Lian Li, PhD, Geoffrey Allen, MD

Blood (2014) 124 (21): 1522.

https://doi.org/10.1182/blood.V124.21.1522.1522

Published: 2014

Journal Articles

Association Of Bleeding Tendency With Time Under Target FIX Activity Levels In Severe Hemophilia B Patients Treated With Recombinant Factor IX Fc Fusion Protein

Amy Shapiro, MD, James Potts, Ph.D, MPH, Shuanglian Li, Ph.D., Leonard A. Valentino, MD, FAAP, Lei Diao, PhD, Ping Wang, Ph.D., Brian Robinson, M.D., Glenn F Pierce, MD, PhD, Haiyan Jiang, PhD

Blood (2013) 122 (21): 2349.

https://doi.org/10.1182/blood.V122.21.2349.2349

Published: 2013

Journal Articles

Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study

Amy Shapiro, MD, John Pasi, MBChB, PhD, FRCP, FRCPath, Johnny Mahlangu, MD, David J. Perry, MD, PhD, FRCP, FRCPath, Jerry S Powell, MD, Margaret V. Ragni, MD, MPH, Leonard A. Valentino, MD, FAAP, Margareth Ozelo, MD, PhD, Karen Nugent, MSc, Shuanglian Li, MD, PhD, Aoife Brennan, MB, BCh, BAO, MMSC, Glenn F Pierce, MD, PhD, Geoffrey Allen, MD

Blood (2013) 122 (21): 2350.

https://doi.org/10.1182/blood.V122.21.2350.2350

Published: 2013

Journal Articles

Pharmacokinetics Of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Pediatric Subjects With Hemophilia A: An Interim Analysis Of The Kids A-LONG Study

Guy Young, MD, Johnny Mahlangu, MD, Beatrice Nolan, MB, MRCPI, FRCPATH, Simon Brown, MD, FRACP, FRCPA, MBBS, FRCP, FRCPath, Leonard A. Valentino, MD, FAAP, Raina Liesner, MA, MBBChir, MD, FRCP, FRCPath, MRCPCH, Yingwen Dong, PhD, Lei Diao, PhD, Haiyan Jiang, PhD, Karen Nugent, MSc, Glenn F. Pierce, MD, PhD, Geoffrey Allen, MD

Blood (2013) 122 (21): 3609.

https://doi.org/10.1182/blood.V122.21.3609.3609

Published: 2013

Journal Articles

The Bleeding Tendency In Relation To Predicted FVIII Activity Levels In Severe Hemophilia A Patients Treated With Recombinant Factor VIII Fc Fusion Protein

John Pasi, MBChB, PhD, FRCP, FRCPath, James Potts, Ph.D, MPH, Shuanglian Li, Ph.D., Ping Wang, Ph.D., Sarah Kulke, M.D., Glenn F Pierce, MD, PhD, Haiyan Jiang, PhD

Blood (2013) 122 (21): 3590.

https://doi.org/10.1182/blood.V122.21.3590.3590

Published: 2013

Journal Articles

Dosing Long-Lasting Recombinant Factor VIII Fc Fusion Protein: Experience In The A-LONG Study

Amy Shapiro, MD, Margaret V. Ragni, MD, MPH, Roshni Kulkarni, MD, Sarah Kulke, M.D., James Potts, Ph.D, MPH, Srividya Neelakantan, Ph.D., Ivan Nestorov, Ph.D., Jennifer A Dumont, PhD, Haiyan Jiang, PhD, Aoife Brennan, MB, BCh, BAO, MMSC, Glenn F Pierce, MD, PhD

Blood (2013) 122 (21): 3598.

https://doi.org/10.1182/blood.V122.21.3598.3598

Published: 2013

Journal Articles

Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: An Interim Analysis Of The Kids B-LONG Study

Kathelijn Fischer, MD, PhD, Roshni Kulkarni, MD, Myles Bradbury, MD, Margaret V. Ragni, MD, MPH, Savita Rangarajan, MBBS, FRCP, FRCPath, Yingwen Dong, PhD, Shuanglian Li, MD, PhD, Haiyan Jiang, PhD, Karen Nugent, MSc, Glenn F Pierce, MD, PhD, Geoffrey Allen, MD

Blood (2013) 122 (21): 3599.

https://doi.org/10.1182/blood.V122.21.3599.3599

Published: 2013

Journal Articles

A Novel Splenocyte Approach for Characterizing T Cell Responses to Adeno-Associated Virus in the Normal Population: Implications on Gene Transfer.

Daniel J. Hui, PhD, Federico Mingozzi, PhD, Marcela V. Maus, MD, PhD, Michael A. Tigges, PhD, Glenn F. Pierce, MD, PhD, Katherine A. High, MD

Blood (2006) 108 (11): 3258.

https://doi.org/10.1182/blood.V108.11.3258.3258

Published: 2006

NARROW

Predicting FIX Activity in Prophylaxis Patients Using Recombinant FIX Fc Fusion Protein for Treatment of Bleeding Episodes

Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously-Treated Children with Severe Hemophilia a (Kids-ALONG)

Predicting FVIII Activity in Patients Who Use Recombinant FVIII Fc Fusion Protein for Prophylaxis and Treatment of Bleeding Episodes

Association Of Bleeding Tendency With Time Under Target FIX Activity Levels In Severe Hemophilia B Patients Treated With Recombinant Factor IX Fc Fusion Protein

Pharmacokinetics, Safety, and Efficacy Of Long-Lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Adolescent Subjects With Hemophilia B: A Subgroup Analysis Of The B-LONG Study

Pharmacokinetics Of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Pediatric Subjects With Hemophilia A: An Interim Analysis Of The Kids A-LONG Study

The Bleeding Tendency In Relation To Predicted FVIII Activity Levels In Severe Hemophilia A Patients Treated With Recombinant Factor VIII Fc Fusion Protein

Dosing Long-Lasting Recombinant Factor VIII Fc Fusion Protein: Experience In The A-LONG Study

Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: An Interim Analysis Of The Kids B-LONG Study

A Novel Splenocyte Approach for Characterizing T Cell Responses to Adeno-Associated Virus in the Normal Population: Implications on Gene Transfer.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only